Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,757
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma

Sha WuDepartment of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaORCID Iconhttps://orcid.org/0000-0003-2802-7806View further author information
ORCID Icon &
Xiaoning LiDepartment of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4596-798XView further author information
ORCID Icon
Pages 1642-1662 | Received 09 Mar 2021, Accepted 23 Apr 2021, Published online: 06 May 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Facai Zhang, Xiaoming Wang, Huan Hu, Yubo Yang, Jiahao Wang, Yin Tang, Dengxiong Li, Yunjin Bai & Ping Han. (2021) A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer. Bioengineered 12:1, pages 3802-3823.
Read now

Articles from other publishers (4)

Yifu Liu, Zhicheng Zhang, Ping Xi, Ru Chen, Xiaofeng Cheng, Ji Liu, Qiqi Zhu, Yechen Nie, Ting Sun, Binbin Gong & Siyuan Wang. (2023) Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma. BMC Cancer 23:1.
Crossref
Nóra Ördög, Barbara N Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Gabriella Pankotai-Bodó, Sarolta Bankó, Farkas Sükösd, Levente Kuthi & Tibor Pankotai. (2022) The clinical significance of epigenetic and RNAPII variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. Translational Oncology 20, pages 101420.
Crossref
Yixiu Yu, Jiamei Niu, Xingwei Zhang, Xue Wang, Hongquan Song, Yingqun Liu, Xiaohui Jiao & Fuyang Chen. (2022) Identification and Validation of HOTAIRM1 as a Novel Biomarker for Oral Squamous Cell Carcinoma. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Jonathan Anker, Justin Miller, Nicole Taylor, Natasha Kyprianou & Che-Kai Tsao. (2021) From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma. Cells 10:11, pages 3231.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.